Depressive behaviour in children diagnosed with a mitochondrial disorder

Mitochondrion

Volumn 10, Issue 5, 2010, Pages 528-533

  Morava, E ^a   Gardeitchik, T ^a   Kozicz, T ^b   de Boer, L ^a   Koene, S ^a   de Vries, M C ^a   McFarland, R ^c   Roobol, T ^a   Rodenburg, R J T ^a   Verhaak, C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Child behavioral checklist; Depression; Depressive behaviour; Mitochondrial medicine; Oxidative phosphorylation

Indexed keywords

ADULT; ARTICLE; BRAIN METABOLISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; FEMALE; HUMAN; HYPOTHESIS; INBORN ERROR OF METABOLISM; MALE; MOOD DISORDER; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; SOTOS SYNDROME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DEPRESSION; FEMALE; HUMANS; INCIDENCE; INFANT; INTERVIEW, PSYCHOLOGICAL; MALE; MITOCHONDRIAL DISEASES; OXIDATIVE PHOSPHORYLATION;

EID: 77955349274     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2010.05.011     Document Type: Article

References (38)

1. Achenbach T.M. Manual for the Child Behavior Checklist/4-18 and 1991 profiles 1991, University of Vermont Department of Psychiatry (Dutch manual version, Verhulst et al. 1996), Burlington, VT.
2. Achenbach T.M., Rescorla L.A. Manual for ASEBA Preschool Forms and Profiles 2000, University of Vermont, Research Center for Children, Youth, and Families, Burlington, VT.
3. Achenbach T.M., Rescorla L.A. Manual for ASEBA Schoolage Forms and Profiles 2001, University of Vermont, Research Center for Children, Youth, and Families, Burlington, VT.
4. Amore M., Tagariello P., Laterza C., Savoia E.M. Subtypes of depression in dementia. Arch. Gerontol. Geriatr. 2007, 44(Suppl. 1):23-33.
5. Amr M., Bakr A., El Gilany A.H., Hammad A., El-Refaey A., El-Mougy A. Multi-method assessment of behavior adjustment in children with chronic kidney disease. Pediatr. Nephrol. 2008, 24(2):341-347. (pub 2008 Nov 4).
6. Bennett D.S. Depression among children with chronic medical problems: a meta-analysis. J. Pediatr. Psychol. 1994, 19:149-169.
7. Cakaloz B., Cakaloz I., Polat A., Inan M., Kalkan Oguzhanoglu N. Psychopathology in thalassemia major. Pediatr. Int. 2009, (3). (PubMedPMID: 19438833, Epub ahead of print).
8. Canning E.H., Kelleher K. Performance of screening tools for mental health problems in chronically ill children. Arch. Pediatr. Adolesc. Med. 1994, 148:227-278.
9. Caplan R., Siddarth P., Gurbani S., Hanson R., Sankar R., Shields W.D. Depression and anxiety disorders in pediatric epilepsy. Epilepsia 2005, 46:720-730.
10. Davis J.D., Tremont G. Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinol. 2007, 32:49-65.
11. de Boer L., Röder I., Wit J.M. Psychosocial, cognitive, and motor functioning in patients with suspected Sotos syndrome: a comparison between patients with and without NSD1 gene alterations. Dev. Med. Child. Neurol. 2006, 48:582-588.
12. Dunn D.W., Austin J.K., Perkins S.M. Prevalence of psychopathology in childhood epilepsy: categorical and dimensional measures. Dev. Med. Child. Neurol. 2009, 51(5):364-372. (PubMed PMID: 19731327).
13. Elliott I.M., Lach L., Kadis D.S., Smith M.L. Psychosocial outcomes in children two years after epilepsy surgery: has anything changed. Epilepsia 2008, 49(4):634-641. (Epub 2007 Dec 28).
14. Fattal O., Link J., Quinn K., Cohen B.H., Franco K. Psychiatric comorbidity in 36 adults with mitochondrial cytopathies. CNS Spectr. 2007, 12:429-438.
15. Finsterer J. Central nervous system manifestations of mitochondrial disorders. Acta Neurol. Scand. 2006, 114:217-238.
16. Gardner A., Johansson A., Wibom R., Nennesmo I., von Döbeln U., Hagenfeldt L., Hällström T. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J. Affect. Disord. 2003, 76:55-68.
17. Greden J.F. The burden of disease for treatment-resistant depression. J. Clin. Psychiatry. 2001, 62:26-31.
18. Hijmans C.T., Grootenhuis M.A., Oosterlaan J., Last B.F., Heijboer H., Peters M., Fijnvandraat K. Behavioral and emotional problems in children with sickle cell disease and healthy siblings: multiple informants, multiple measures. Pediatr. Blood Cancer 2009, 53(7):1277-1283. (PubMed PMID: 19731327).
19. Hutchison W.M., Thyagarajan D., Poulton J., Marchington D.R., Kirby D.M., Manji S.S., Dahl H.H. Clinical and molecular features of Encephalomyopathy due to the A3302G mutation in the mitochondrial tRNALeu(UUR) Gene. Arch. Neurol. 2005, 62:1920-1923.
20. Janssen A.J., Trijbels F.J., Sengers R.C., Wintjes L.T., Ruitenbeek W., Smeitink J.A., Morava E., van Engelen B.G., van den Heuvel L.P., Rodenburg R.J. Measurement of the energy-generating capacity of human muscle mitochondria: diagnostic procedure and application to human pathology. Clin. Chem. 2006, 52:860-871.
21. Koene S., Kozicz T.L., Rodenburg R.J., Verhaak C.M., de Vries M.C., Wortmann S., van de Heuvel L., Smeitink J.A., Morava E. Major depression in adolescent children consecutively diagnosed with mitochondrial disorder. J. Affect. Disord. 2009, 114:327-332.
22. McEwen B.S., Wingfield J.C. The concept of allostasis in biology and biomedicine. Horm. Behav. 2003, 43:2-15.
23. Meuret A.E., Ehrenreich J.T., Pincus D.B., Ritz T. Prevalence and correlates of asthma in children with internalizing psychopathology. Depress. Anxiety 2006, 23:502-508.
24. Miovic M., Block S. Psychiatric disorders in advanced cancer. Cancer 2007, 110:1665-1676.
25. Morava E., van den Heuvel L., Hol F., de Vries M.C., Hogeveen M., Rodenburg R.J., Smeitink J.A. Mitochondrial disease criteria: diagnostic applications in children. Neurology 2006, 67:1823-1826.
26. Morton M.J., Reynolds J.M., Garralda M.E., Postlethwaite R.J., Goh D. Psychiatric adjustment in end-stage renal disease a follow up study of former pediatric patients. J. Psychosom. Res. 1994, 38:293-303.
27. Munakata K., et al. Mitochondrial DNA 3644 T-C mutation associated with bipolar disorder. Genomics 2004, 84:1041-1050.
28. Munakata K., Iwamoto K., Bundo M., Kato T. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol. Psychiatry 2005, 57:525-532.
29. Rosenblatt A. Neuropsychiatry of Huntington's disease. Dialogues Clin. Neurosci. 2007, 9:191-197.
30. Schaefer A.M., Taylor R.W., Turnbull D.M., Chinnery P.F. The epidemiology of mitochondrial disorders-past, present and future. Biochim. Biophys. Acta 2004, 1659:115-120.
31. Smeitink J.A., Zeviani M., Turnbull D.M., Jacobs H.T. Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell. Metab. 2006, 3:9-13.
32. Väistö T., Aronen E.T., Simola P., Ashorn M., Kolho K.L. Psychosocial symptoms and competence among adolescents with inflammatory bowel disease and their peers. Inflamm Bowel Dis. 2010, 16(1):27-35. (PubMed PMID: 19575356).
33. van Handel M., Swaab H., de Vries L.S., Jongmans M.J. Behavioral outcome in children with a history of neonatal encephalopathy following perinatal asphyxia. J. Pediatr. Psychol. 2009, (19). ([Epub ahead of print] PubMed PMID: 19542199).
34. Verhulst F.C., van der Ende J., Ferdinand R.F., Kasius M.C. The Prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents. Arch. Gen. Psychiatry 1997, 54:329-336.
35. Warnick E.M., Bracken M.B., Kasl S. Screening efficiency of the child behavior checklist and strengths and difficulties questionnaire: a systematic review. Adolesc. Ment. Health 2008, 13:140-147.
36. Whitsett S.F., Gudmundsdottir M., Davies B., McCarthy P., Friedman D. Chemotherapy-related fatigue in childhood cancer: correlates, consequences, and coping strategies. J. Pediatr. Oncol. Nurs. 2008, 25:86-96.
37. Wray J., Radley-Smith R. Depression in pediatric patients before and 1year after heart or heart-lung transplantation. J. Heart Lung Transplant. 2004, 23:1103-1110.
38. Yu Y.W., Tsai S.J., Hong C.J., Chen T.J., Chen M.C., Yang C.W. Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response. Neuropsychopharmacology 2005, 30:1719-1723.